| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |